Proficio Capital Partners’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$262K Buy
+2,901
New +$243K 0.01% 562
2022
Q1
Sell
-1,839
Closed -$238K 300
2021
Q4
$238K Buy
1,839
+13
+0.7% +$1.52K 0.03% 261
2021
Q3
$207K Buy
+1,826
New +$208K 0.03% 287
2019
Q3
Sell
-759
Closed -$47K 596
2019
Q2
$47K Buy
759
+150
+25% +$9.07K 0.02% 396
2019
Q1
$39K Buy
609
+81
+15% +$4.62K 0.01% 421
2018
Q4
$27K Buy
528
+9
+2% +$455 0.01% 460
2018
Q3
$30K Sell
519
-15
-3% -$734 0.01% 472
2018
Q2
$26K Hold
534
0.01% 518
2018
Q1
$25K Buy
534
+69
+15% +$3K 0.01% 526
2017
Q4
$17K Sell
465
-174
-27% -$6.39K 0.01% 630
2017
Q3
$23K Hold
639
0.01% 550
2017
Q2
$24K Buy
639
+18
+3% +$657 0.01% 550
2017
Q1
$24K Buy
621
+327
+111% +$10.2K 0.01% 561
2016
Q4
$9K Sell
294
-135
-31% -$4.37K ﹤0.01% 626
2016
Q3
$17K Buy
429
+63
+17% +$2.37K 0.01% 462
2016
Q2
$14K Buy
366
+195
+114% +$6.67K 0.01% 496
2016
Q1
$5K Hold
171
﹤0.01% 512
2015
Q4
$5K Buy
+171
New +$4.44K ﹤0.01% 415

Other funds holding EW

Proficio Capital Partners's EW Position: Q2 2026 in Review

Proficio Capital Partners opened a new position in Edwards Lifesciences (EW) in Q2 2026: 2,901 shares worth $262K. The stake represents 0.01% of the portfolio and ranks #562 among its holdings. This is a return to the name: Proficio Capital Partners previously reported a position in EW as recently as Q4 2021.

Proficio Capital Partners first reported a position in EW in Q4 2015 and has held it in 18 quarters since. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Proficio Capital Partners held 2,901 shares of Edwards Lifesciences worth $262K as of Q2 2026.
  • Edwards Lifesciences was a new Proficio Capital Partners position in Q2 2026.
  • Edwards Lifesciences made up 0.01% of Proficio Capital Partners's portfolio in Q2 2026, its #562 holding.
  • Proficio Capital Partners first reported a position in Edwards Lifesciences in Q4 2015 and has held it in 18 quarters since.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Proficio Capital Partners's 13F filing for Q2 2026, filed 17 Aug 2026.